12:00 AM
 | 
Aug 20, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Oculus, More Pharma Corp. sales and marketing update

Oculus granted More Pharma an exclusive license to its Microcyn-based products in Mexico, South and Central America, and the Caribbean. Oculus will receive a $5.1 million upfront...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >